Skip to main content
. 2010 Oct;70(4):471–480. doi: 10.1111/j.1365-2125.2010.03680.x

Table 3.

Posaconazole peak (Cmax) and average (Cavg) concentrations may be of predictive value in patients with invasive aspergillosis treated with 400 mg twice daily [37]

Cmax (µg ml−1) Cavg (µg ml−1) Response
0.142 0.134 24% (4 of 17)
0.467–0.852 0.411–0.719 >53% (18 of 34)
1.48 1.25 75% (12 of 16)